The Psoriatic Arthritis Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Psoriatic arthritis is a form of arthritis that affects some people who have psoriasis - a condition that features red patches of skin topped with silvery scales. Most people develop psoriasis first and are later diagnosed with psoriatic arthritis, but the joint problems can sometimes begin before skin patches appear. Joint pain, stiffness, and swelling are the main signs and symptoms of psoriatic arthritis. Psoriatic arthritis can affect any part of your body, including your fingertips and spine, and can range from relatively mild to severe. Psoriatic arthritis can affect joints on just one side or on both sides of the body. The signs and symptoms of psoriatic arthritis often resemble those of rheumatoid arthritis. Psoriatic arthritis causes:

• Swollen fingers and toes
• Foot pain
• Lower back pain

Market Dynamics

Key players are focused on gaining approvals from regulatory bodies in order to expand their product portfolio. This is expected to propel the growth of the global psoriatic arthritis market during the forecast period. For instance, in July 2013, Janssen-Cilag International NV (Janssen) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the use of STELARA (ustekinumab), alone or in combination with methotrexate, for the treatment of active psoriatic arthritis in adult patients when the response to previous non-biological disease-modifying anti-rheumatic drug (DMARD) therapy has been inadequate.

Increasing number of drugs approvals from regulatory bodies is the major factor driving the market growth over the forecast period. For instance, in January 2019, Sandoz Canada Inc., a division of Novartis AG, announced that Health Canada has approved Erelzi (etanercept), a biosimilar of Enbrel (etanercept), for the treatment of psoriatic arthritis (PsA) in adult patients, making Erelzi the only etanercept biosimilar to have obtained approval for this indication in Canada.

Key features of the study:

• This report provides an in-depth analysis of global psoriatic arthritis market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global psoriatic arthritis market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
• Key companies covered as a part of this study include AbbVie, Inc., Amgen, Inc., Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer, Inc., UCB S.A., and AstraZeneca plc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global psoriatic arthritis market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the psoriatic arthritis market.

Detailed Segmentation:

Global Psoriatic Arthritis Market, By Drug Class:

• Non-steroidal Anti-inflammatory Drugs (NSAIDS)
• Disease-modifying Antirheumatic Drugs (DMARDs)
• Biologics
• Others

Global Psoriatic Arthritis Market, By Product Type:

• Prescription
• Over The Counter

Global Psoriatic Arthritis Market, By Route of Administration:

• Topical
• Oral
• Injectable

Global Psoriatic Arthritis Market, By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Psoriatic Arthritis Market, By Region:

• North America
• By Country:
• U.S.
• Canada
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country:
• U.K.
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe
• Asia Pacific
• By Country:
• Australia
• India
• China
• Japan
• ASEAN
• South Korea
• Rest of Asia Pacific
• Middle East
• By Country:
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Region:
• South Africa
• Central Africa
• North Africa
• Company Profiles
• AbbVie, Inc. *
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
• Amgen, Inc..
• Johnson & Johnson Services, Inc.
• Bristol-Myers Squibb Company
• Celgene Corporation
• Novartis International AG
• Eli Lilly and Company
• Pfizer, Inc.
• UCB S.A.
• AstraZeneca plc.